Product Overview
Trimbow 100 6 12.5 Inhaler by Chiesi is a combination medication used to treat chronic obstructive pulmonary disease (COPD). It contains three active ingredients - Beclometasone Dipropionate, Formoterol, and Glycopyrronium Bromide - that work together to help improve lung function and reduce symptoms such as shortness of breath and coughing.

Key Benefits
- Triple-action formula for maximum effectiveness
- Reduces inflammation in the airways
- Dilates the bronchial tubes for easier breathing
- Long-lasting relief from COPD symptoms
- Convenient inhaler format for easy use on-the-go

How It Works
Beclometasone Dipropionate is a corticosteroid that reduces inflammation in the airways, while Formoterol is a long-acting beta agonist that helps to dilate the bronchial tubes. Glycopyrronium Bromide is an anticholinergic that helps to relax the muscles around the airways. Together, these three ingredients work synergistically to improve lung function and provide relief from COPD symptoms.

Directions for Use
1. Shake the inhaler well before each use.
2. Remove the cap and exhale fully.
3. Place the mouthpiece in your mouth and inhale deeply while pressing down on the canister to release the medication.
4. Hold your breath for a few seconds before exhaling slowly.
5. Rinse your mouth with water after each use to prevent thrush.

Precautions
- Do not exceed the recommended dose.
- Avoid using other bronchodilators without consulting your doctor.
- Inform your healthcare provider if you have any heart conditions or high blood pressure.
- Seek medical attention if you experience worsening symptoms or difficulty breathing.

Storage Instructions
Store Trimbow 100 6 12.5 Inhaler at room temperature away from direct sunlight and moisture. Keep out of reach of children and pets.

Manufacturer Information
Chiesi is a global pharmaceutical company dedicated to improving the health and well-being of patients worldwide. With a focus on respiratory and neonatal care, Chiesi is committed to developing innovative medications to meet the needs of patients with chronic conditions like COPD.